These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25365149)

  • 1. Hyper-IgE syndromes: reviewing PGM3 deficiency.
    Yang L; Fliegauf M; Grimbacher B
    Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.
    Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B
    J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-IgE Syndromes and the Lung.
    Freeman AF; Olivier KN
    Clin Chest Med; 2016 Sep; 37(3):557-67. PubMed ID: 27514600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation.
    Wu G; Hitchen PG; Panico M; North SJ; Barbouche MR; Binet D; Morris HR; Dell A; Haslam SM
    Glycoconj J; 2016 Jun; 33(3):447-56. PubMed ID: 26687240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene.
    Lundin KE; Hamasy A; Backe PH; Moens LN; Falk-Sörqvist E; Elgstøen KB; Mørkrid L; Bjørås M; Granert C; Norlin AC; Nilsson M; Christensson B; Stenmark S; Smith CI
    Clin Immunol; 2015 Dec; 161(2):366-72. PubMed ID: 26482871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients.
    Ben-Khemis L; Mekki N; Ben-Mustapha I; Rouault K; Mellouli F; Khemiri M; Bejaoui M; Essaddam L; Ben-Becher S; Boughamoura L; Hassayoun S; Ben-Ali M; Barbouche MR
    Mol Immunol; 2017 Oct; 90():57-63. PubMed ID: 28704707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.
    Zhang Y; Yu X; Ichikawa M; Lyons JJ; Datta S; Lamborn IT; Jing H; Kim ES; Biancalana M; Wolfe LA; DiMaggio T; Matthews HF; Kranick SM; Stone KD; Holland SM; Reich DS; Hughes JD; Mehmet H; McElwee J; Freeman AF; Freeze HH; Su HC; Milner JD
    J Allergy Clin Immunol; 2014 May; 133(5):1400-9, 1409.e1-5. PubMed ID: 24589341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on Syndromes with a Hyper-IgE Phenotype.
    Bergerson JRE; Freeman AF
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.
    Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikström AC; Fasth A; Ekwall O; Smith CIE
    BMC Pediatr; 2018 Aug; 18(1):285. PubMed ID: 30157810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Immunodeficiencies with Elevated IgE.
    Mogensen TH
    Int Rev Immunol; 2016; 35(1):39-56. PubMed ID: 25970001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hyper-IgE syndrome: singular or plural?
    Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
    Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper-IgE syndromes.
    Garib V; Ben-Ali M; Kundi M; Curin M; Yaakoubi R; Ben-Mustapha I; Mekki N; Froeschl R; Perkmann T; Valenta R; Barbouche MR
    Allergy; 2022 Jun; 77(6):1761-1771. PubMed ID: 34653276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients.
    Jacob M; Masood A; Abdel Rahman AM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features.
    García-García A; Buendia Arellano M; Deyà-Martínez À; Lozano Blasco J; Serrano M; Van Den Rym A; García-Solis B; Esteve-Solé A; Yiyi L; Vlagea A; Solanich X; Fisher MR; Lyons JJ; de Diego RP; Alsina L
    Pediatr Allergy Immunol; 2021 Apr; 32(3):566-575. PubMed ID: 33098103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations.
    Fusaro M; Vincent A; Castelle M; Rosain J; Fournier B; Veiga-da-Cunha M; Kentache T; Serre J; Fallet-Bianco C; Delezoide AL; Renesme L; Picard FM; Lasseaux E; Aladjidi N; Seta N; Cormier-Daire V; Schaftingen EV; Neven B; Moshous D; Blesson S; Picard C
    J Clin Immunol; 2021 Jul; 41(5):958-966. PubMed ID: 33534079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
    Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
    J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
    Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
    Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyper-IgE syndrome. Lessons from function and defects of STAT-3 or DOCK-8].
    Alcántara-Montiel JC; Vega-Torres BI
    Rev Alerg Mex; 2016; 63(4):385-396. PubMed ID: 27795219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.